Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2007-12-6
pubmed:databankReference
pubmed:abstractText
Experience of pain in major depressive disorder (MDD) can complicate diagnosis and impair treatment outcomes. This study evaluated the efficacy and safety of duloxetine in the treatment of patients with moderate pain associated with depression.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1555-2101
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
68
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1707-16
pubmed:dateRevised
2008-9-4
pubmed:meshHeading
pubmed-meshheading:18052564-Adolescent, pubmed-meshheading:18052564-Adult, pubmed-meshheading:18052564-Aged, pubmed-meshheading:18052564-Aged, 80 and over, pubmed-meshheading:18052564-Antidepressive Agents, pubmed-meshheading:18052564-Depressive Disorder, Major, pubmed-meshheading:18052564-Diagnostic and Statistical Manual of Mental Disorders, pubmed-meshheading:18052564-Dose-Response Relationship, Drug, pubmed-meshheading:18052564-Double-Blind Method, pubmed-meshheading:18052564-Drug Tolerance, pubmed-meshheading:18052564-Female, pubmed-meshheading:18052564-Humans, pubmed-meshheading:18052564-Male, pubmed-meshheading:18052564-Middle Aged, pubmed-meshheading:18052564-Pain, pubmed-meshheading:18052564-Pain Measurement, pubmed-meshheading:18052564-Severity of Illness Index, pubmed-meshheading:18052564-Thiophenes
pubmed:year
2007
pubmed:articleTitle
Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.
pubmed:affiliation
Boehringer Ingelheim GmbH, Ingelheim, Germany. BRECHTS@ing.boehringer-ingelheim.com
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't